Skip to main content

Fatal pediatric case of Kounis syndrome and sepsis: a case report

Abstract

Background

Kounis syndrome is a hypersensitivity reaction that induces acute coronary artery events, nevertheless its pediatric occurrence remains rare and often underdiagnosed. This report describes a fatal case of Kounis syndrome triggered by ceftriaxone-lidocaine administration in a child, in the context of sepsis and multiple organ dysfunction syndrome.

Case presentation

A 4-year girl with a history of cyclic vomiting syndrome, was admitted to the ICU with severe lethargy and pallor 30 min after the second intramuscular injection of ceftriaxone, which had been prescribed for vomiting, diarrhea, and fever. Her laboratories were pertinent for a metabolic acidosis, neutrophilic leukocytosis, renal dysfunction, elevated cardiac markers (troponin I and cardiac-type creatine phosphokinase), EKG signs of myocardial ischemia, bilateral bronchopneumonia, and right lower multifocal pneumonia. Despite intensive management, the patient’s condition continued to deteriorated, which lead to multiple organ dysfunction and eventual death.

Conclusion

This case highlights the need for heightened clinical awareness of Kounis syndrome in pediatric settings, especially in patients with underlying infections. This case underscores the fatal potential of undiagnosed Kounis syndrome in the pediatric population and highlights the urgent need for enhanced vigilance and multidisciplinary preparedness.

Introduction

Kounis syndrome is a hypersensitivity reaction triggered by allergy or anaphylaxis, potentially leading to acute coronary syndrome [1]. The first clinical case of Kounis syndrome was described in 1950 and the first pediatric case was reported in 2009 [2]. Despite increasing medical attention, Kounis syndrome remains underreported and underdiagnosed, as it is considered to be a rare and challenging diagnosis [3]. Herein, we present a fatal case of Kounis syndrome in a child with sepsis, infectious-toxic shock, and multiple organ dysfunction syndrome.

Case report

Patient information

A 4-year-old girl was urgently admitted to the ICU of the Regional Children’s Clinical Hospital at 240 a.m.

Signs and symptoms

Severe lethargy, pallor, and delayed responsiveness, which developed 30 min after the second intramuscular injection of ceftriaxone with lidocaine.

Clinical course before admission

Her parents denied any medical history of respiratory or other infections within 3 weeks before her admission. The illness developed acutely and was characterized by fever, vomiting, and diarrhea. There were no noted skin manifestations. Due to the patient developing these acute symptoms, her parents were referred to the primary health care unit for treatment of a likely bacterial infection. Considering the severity of the patient’s condition and the absence of bacteriological test results and antibiotic susceptibility data, ceftriaxone was empirically chosen as a broad-spectrum antibiotic for management of her likely bacterial infection.

Medical and family history

The parents denied a history of any significant medical conditions except for cyclic vomiting syndrome, which occurred several times over the past year. Her family history was pertinent only for type 2 diabetes mellitus. The parents denied any known allergies and she was up to date on routine vaccinations for her age.

Timeline

Date/Time

Event Description

Day 1

Onset of fever, vomiting, and diarrhea

Day 2

Initial hospital admission with suspected infection intestinal disease; starting management with ceftriaxone

Day 2 (9:00 pm)

Development of allergic reaction (30 min after the second dose of ceftriaxone)

Day 3 (2:40 am)

Transferred to Regional Children’s Hospital ICU

Day 3 (09:00 am)

Worsening condition, placed on mechanical ventilation, pharmacologic coma induced

Day 3 (1:30 pm)

Progressive decline in ejection fraction to 15%

Day 3 (8:00 pm)

Progressive deteriorating coagulation parameters

Day 3 (10:10 pm)

Asystole occurred

Day 3 (10:40 pm)

Death of the patient

Clinical findings

The patient was a well-nourished girl with a body weight of 20 kg (+ 1σ). Vital signs included a body temperature of 36.5 °C and saturation (SpO₂) between 96% and 88%. The skin was markedly pale and dry and exhibited reduced turgor with perioral cyanosis. The child was stuporous (Glasgow Coma Scale score of 12 and a white spot test > 5 s), tachypnenic with a respiratory rate of 24 breaths per minute. On auscultation, there was diminished breath sounds, scattered moist rales, dullness in the lower lung fields bilaterally. She was tachycardic with a heart rate of 138 bpm, and on cardiac auscultation she had weak heart sounds. Her blood pressure on admission was 140/100 mmHg, nevertheless, it decreased to 75/35 mmHg. There was no organomegaly on abdominal exam with the liver palpable 1.5 cm below the costal margin. Unfortunately, the spleen was not palpable during the physical exam. The patient had been anuric for the past 24 h. The diarrhea (7–8 times daily) over the last 48 h, which coincided with the onset of fever and vomiting.

Diagnostic assessment

SARS-CoV-2 antigen rapid test: negative.

Laboratory analysis revealed anemia, neutrophilic leukocytosis, and elevated inflammatory markers. In addition there was a noted metabolic acidosis, hypoproteinemia, renal dysfunction, elevated liver enzymes, and hypoglycemia. Cardiac biomarkers and D-dimer levels were markedly elevated. All laboratory findings can be seen in Table 1. Coagulation parameters at two-time points are summarized in Table 2.

Table 1 Laboratory findings
Table 2 Coagulation parameters at different time points

Upon admission to the ICU of the Regional Children’s Clinical Hospital, stool, urine, and blood samples were collected for microbiological testing. Nevertheless, these were non-revealing as the results were negative, with no microorganisms identified.

Electrocardiography (ECG) revealed sinus tachycardia with clinically significant ST-segment depression (Fig. 1).

Fig. 1
figure 1

The ECG findings with signs of subendocardial myocardial ischemia. Arrows indicate ST-segment depression

Table 3 Echocardiographic findings at different time points

Echocardiography revealed significant cardiac impairment (Table 3). Moderate mitral and tricuspid valve insufficiency were present, but myocardial wall thickness remained normal. No coronary artery abnormalities were observed.

Chest X-ray: bilateral bronchopneumonia and multifocal pneumonia in the right lower lobe.

Ultrasonography revealed renal parenchyma with markedly increased echogenicity and reduced systolic flow, no other significant changes were noted.

Therapeutic intervention

Upon admission, the patient’s condition worsened due to multiple organ dysfunction syndrome, hemodynamic instability, and toxicosis (Phoenix Sepsis Score − 8). At 9:00 a.m., the child was placed on mechanical ventilation and induced into a pharmacologic coma (dobutamine 5–20 µg/kg/min, norepinephrine 0.2 µg/kg/min, dopamine 10 µg/kg/min, morphine 0.2 µg/kg). The treatment regimen included dobutamine, norepinephrine, dopamine, levosimendan, hydrocortisone, dexamethasone, chlorpyramine, morphine, diazepam, and meropenem. At 10:10 p.m., asystole was observed, and despite resuscitation efforts, the death occurred at 10:40 p.m.

Outcomes

The pathological autopsy report: subtotal bacterial necrotizing pneumonia, complicated by sepsis, which manifested as bacterial thrombovasculitis affecting the intrapulmonary, splenic, mesenteric and renal vessels, along with infectious-toxic shock, severe circulatory disturbances, and dystrophic changes. Additional findings included Waterhouse-Friderichsen syndrome, cerebral edema with brain swelling, leukomalacia, pulmonary edema, and vacuolar degeneration of hepatocytes, cardiomyocytes, and renal tubular epithelium, all against a background of thymic hypoplasia. The key findings are presented in Fig. 2.

Fig. 2
figure 2

The histopathological findings. A – Fragment of jejunum with edematous mucosa and neutrophilic inflammatory infiltrates. Desquamation of the epithelium with a tendency toward erosive changes, signs of active crypt epithelial regeneration, and occasional crypt abscesses are observed (acute bacterial enteritis). B – Lung tissue with thickened interalveolar septa and mononuclear inflammatory infiltrates with admixture of neutrophils. The alveolar epithelium is flattened and damaged; numerous hyaline membranes are observed. Occasional alveolar spaces contain exudate. Vascular congestion and microthrombosis (pneumonia-associated diffuse alveolar damage). C – Adrenal gland with massive extravasation of erythrocytes (hemorrhage) into the cortical and medullary regions, causing disruption of the gland’s histoarchitecture. Microloci of coagulative necrosis with loss of cellular borders and karyolysis. Microloci of inflammatory reaction zones (Waterhouse-Friderichsen syndrome). D – Renal medulla with mostly preserved histoarchitecture. Foci of tubules show necrotic and apoptotic epithelial changes. Numerous vessels exhibit signs of stasis and thrombosis, with single perivascular inflammatory cells present (focal acute tubular necrosis of renal tubular epithelium, signs of thrombovasculitis)

The final clinical diagnosis: Bilateral focal necrotizing pneumonia with abscess formation, complicated by toxic syndrome and grade III respiratory failure; infectious-toxic shock; sepsis with multiple organ dysfunction syndrome; anaphylactic shock; and Kounis syndrome, type I.

Discussion

Kounis syndrome remains underdiagnosed globally due to limited awareness among clinicians. Despite an incidence of 19.4 per 100,000 hospital admissions and a low fatality rate (0.0001%), it is frequently overlooked in clinical practice [4, 5]. While predominantly observed in adults, its incidence in children is six times lower (3.3 per 100,000 inhabitants) [6].

Diagnosis relies on clinical presentation, ECG and echocardiography findings, and laboratory markers [7]. Symptoms often include allergic reactions with variable ECG changes [4], making laboratory tests (e.g., cardiac enzymes, troponins) crucial for confirmation [8]. However, the case with clinical manifestation of anaphylaxis and ECG signs (ST elevation) without significant laboratory findings (normal troponin level and coagulation parameters) is reported [9], additionally highlighting diagnostic challenges. In our case, the second dose of ceftriaxone-lidocaine administration led to cardiovascular compromise within 30 min (subendocardial ischemia, elevated serum troponin I and CK-MB levels), meeting criteria of anaphylaxis according to [10]. According to a systematic review of pediatric patients with Kounis syndrome [11], ST elevation is far more common (63.6%) than ST depression (18.2%). Symptom onset varies significantly (from less than 30 min to 4–6 h after exposure to triggers), with elevated serum troponin I observed in 81.8% of cases and increased CK-MB levels in 63.6%, findings that align with our case. Youcefi HE et al. noted ECG ischemia changes in 95% of cases and elevated cardiac enzymes in 85% [12]. However, a decreased EF (< 50%), as observed in our case, was reported in only 25% of pediatric cases [12].

The fatal outcome in this case resulted from a combination of Kounis syndrome and sepsis with multiple organ dysfunction syndrome. However, at the time of initial hospital admission, the patient presented only with fever, diarrhea, and vomiting, without any other complaints or signs. Due to the circumstances of illness onset (acute onset at a holiday destination) and the lack of advanced healthcare opportunities at the local primary healthcare unit, empirical antibiotic treatment was initiated. Hosoda T et al. described a case of enterocolitis with SARS-CoV-2 excretion without any respiratory symptoms or fever but with a negative SARS-CoV-2 PCR test on throat swabs [13]. Vendargon S et al. documented three pediatric cases where patients initially presented with abdominal pain, but pneumonia was later diagnosed [14]. In one case, microbiological testing was negative, Gram-negative bacilli were isolated from pus in another, and Staphylococcus aureus was identified in the third. Similarly, Naccour J et al. described a 44-year-old male admitted with abdominal pain and vomiting, without respiratory complaints; however, auscultation a few days later revealed right basal crackles, and pneumonia was confirmed by chest X-ray [15]. Zeng S et al. reported an episode of acute hemorrhagic necrotizing enteritis progressing to bilateral pneumonia with consolidation, and severe sepsis and septic shock [16]. However, the patient’s condition deteriorated rapidly due to the development of sepsis and multiorgan dysfunction syndrome, including respiratory failure, leading to oxidative stress imbalance and the progression of metabolic acidosis [17, 18]. In addition, concurrently a hypersensitivity reaction culminated in acute coronary syndrome, resulting in a fatal outcome within less than a day.

The triggers of Kounis syndrome are diverse and include medical drugs, food, vaccines, and insect stings. Among drugs, antibiotics are frequent triggers, particularly in adults [4, 12], including but not limited by amoxicillin, ampicillin, amikacin, ceftriaxone, cephalosporin, cephazolin, cefoxitin, cefuroxime, cephaloridine, cinoxacin, lincomycin, penicillin, ampicillin/sulbactam, sulbactam/cefoperazone, piperacillin/tazobactam, trimethoprim-sulfamethaxazole, sulperazon, vancomycin [4, 12, 19,20,21,22]. In pediatric cases, Kounis syndrome is most commonly associated with amoxicillin/clavulanic acid [11, 12], with no documented cases linked to cephalosporins having been reported. While the likelihood of cross-reactivity between penicillins and cephalosporins is considered negligible [23, 24], it is not entirely impossible. Therefore, prescribing antibiotics to patients should be approached with caution due to the potential risk of an allergic reaction and Kounis syndrome development. In the presented clinical episode, intramuscular injection of ceftriaxone-lidocaine led to Kounis syndrome. On the other hand, local anesthetics may also act as triggers, as reported in adult case studies [12, 25, 26]. However, despite the lack of reported cases in the pediatric population, their role in inducing Kounis syndrome cannot be excluded [12].

Conclusion

This case highlights the diagnostic challenges of Kounis syndrome in pediatric patients, particularly along with severe infectious complications. The fatal outcome underscores the importance of considering allergic myocardial involvement in critically ill children with signs of cardiac ischemia following drug administration. Increased awareness and early recognition of Kounis syndrome could improve outcomes through timely intervention and tailored therapeutic strategies.

Data availability

No datasets were generated or analysed during the current study.

References

  1. Douedi S, Odak M, Mararenko A, Ross J, Sealove B, Kounis Syndrome. A review of an uncommon cause of acute coronary syndrome. Cardiol Rev. 2022;31(4):230–2. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/CRD.0000000000000436.

    Article  PubMed  Google Scholar 

  2. Biteker M, Ekşi Duran N, Sungur Biteker F, Ayyıldız Civan H, Kaya H, Gökdeniz T, et al. Allergic myocardial infarction in childhood: Kounis syndrome. Eur J Pediatrics. 2009;169(1):27–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00431-009-0965-5.

    Article  Google Scholar 

  3. Cahuapaza-Gutierrez NL, Calderon-Hernandez CC, Chambergo-Michilot D, De Arruda-Chaves E, Zamora A, Runzer-Colmenares FM. Clinical characteristics, management, diagnostic findings, and various etiologies of patients with Kounis syndrome. A systematic review. Int J Cardiol. 2025;418:132606. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ijcard.2024.132606.

    Article  PubMed  Google Scholar 

  4. Kounis NG. Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med (CCLM). 2016;54(10):1545–59. https://doiorg.publicaciones.saludcastillayleon.es/10.1515/cclm-2016-0010.

    Article  PubMed  CAS  Google Scholar 

  5. Forzese E, Pitrone C, Cianci V, Sapienza D, Ieni A, Tornese L, et al. An insight into Kounis syndrome: bridging clinical knowledge with forensic perspectives. Life. 2024;14(1):91. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/life14010091.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Mori F, Barni S, Saretta F, Castagnoli R, Arasi S, Mastrorilli C, et al. Epidemiology of rare allergic diseases in children. Pediatr Allergy Immunol. 2020;31(S26):39–42. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/pai.13359.

    Article  PubMed  Google Scholar 

  7. Boarescu I, Boarescu PM. Drug-Induced myocardial infarction: A review of Pharmacological triggers and pathophysiological mechanisms. J Cardiovasc Dev Disease. 2024;11(12):406. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/jcdd11120406.

    Article  CAS  Google Scholar 

  8. Kounis NG, Koniari I, Velissaris D, Tzanis G, Hahalis G. Kounis Syndrome—not a Single-organ arterial disorder but a multisystem and multidisciplinary disease. Balkan Med J. 2019;36(4):212–21. https://doiorg.publicaciones.saludcastillayleon.es/10.4274/balkanmedj.galenos.2019.2019.5.62.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Cesarz T, Ganti L. Kounis syndrome: ST elevations in the setting of anaphylaxis. J Allergy Clin Immunology: Global. 2023;2(4):100152. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jacig.2023.100152.

    Article  Google Scholar 

  10. Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M, Fineman S et al. World Allergy Organization Anaphylaxis Guidance 2020. World Allergy Organization Journal. 2020;13(10):100472. Available from: https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.waojou.2020.100472

  11. Giovannini M, Alletto A, Koniari I, Mori F, Favilli S, Sarti L, et al. Kounis syndrome: a pediatric perspective. Minerva Pediatr. 2020;72(5):383–92. https://doiorg.publicaciones.saludcastillayleon.es/10.23736/S0026-4946.20.06007-7.

    Article  PubMed  Google Scholar 

  12. Youcefi HE, Abu Saadeh A, Karaca G, Kimiaei A, Safaei S, Kaya A. Exploring variations in etiology and clinical presentations of Kounis syndrome across pediatric and adult populations: A comprehensive review. Cureus. 2024;16(3):e56249. https://doiorg.publicaciones.saludcastillayleon.es/10.7759/cureus.56249.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hosoda T, Sakamoto M, Shimizu H, Okabe N. SARS-CoV-2 Enterocolitis with persisting to excrete the virus for approximately two weeks after recovering from diarrhea: A case report. Infect Control Hosp Epidemiol. 2020;41(6):753–4. https://doiorg.publicaciones.saludcastillayleon.es/10.1017/ice.2020.87.

    Article  PubMed  CAS  Google Scholar 

  14. Vendargon S, Wong PS, Tan KK. Pneumonia presenting as acute abdomen in children: a report of three cases. Med J Malaysia. 2000;55(4):520–3. PMID: 11221169.

    PubMed  CAS  Google Scholar 

  15. Naccour J, Sabra H, Alimoradi M, El-Helou E, Haddad MM, Bitar H. Rare presentation of community acquired pneumonia resulted in laparoscopic intervention in adult. Case report. Int J Surg Case Rep. 2020;75:214–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ijscr.2020.09.046.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Zeng S, Tsia Hin Fong CJ, Li L, Liang Y, Liang Q, Wei B, et al. Acute hemorrhagic necrotizing enteritis: a case report and review of the literature. Annals Palliat Med. 2020;9(6):3–3. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/apm-20-1131.

    Article  Google Scholar 

  17. Arı HF, Arı M, Ogut S. Oxidative stress and anti-oxidant status in children with sepsis. BMC Pharmacol Toxicol. 2025;26(1):64. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40360-025-00895-2.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Matskevych V, Ilnytska K, Lenchuk T, Mytsyk Y, Kindrativ E, Hlushko N. Multiple myeloma patient with secondary liver and tongue involvement, complicated by COVID-19-Induced ARDS: an autopsy case report and literature review. Galician Med J. 2024;31(1):e-GMJ2024-A01. https://doiorg.publicaciones.saludcastillayleon.es/10.21802/e-GMJ2024-A01

  19. Almegbel M, Alshamardl K, Aleshaiwi L, Almutairi F, Kounis Syndrome. A case report and a review of recent literature. Cureus. 2024;16(7):e64627. https://doiorg.publicaciones.saludcastillayleon.es/10.7759/cureus.64627.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kumaran T, Damodaran S, Singh AP, Kanchi M. Intraoperative cardiac arrest due to allergic acute coronary syndrome (Kounis syndrome) triggered by cephalosporin. Ann Card Anaesth. 2023;26(2):219–22. https://doiorg.publicaciones.saludcastillayleon.es/10.4103/aca.aca_302_20.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Leibee C, Getachew B, Ehmann MR. Vancomycin-induced Kounis syndrome. Am J Emerg Med. 2019;37(9):1806.e3–1806.e5. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ajem.2019.06.004.

    Article  Google Scholar 

  22. Berezna TG, Synoverska OB, Fomenko NM, et al. Kounis syndrome: Terra incognita. Mod Pediatr Ukraine. 2023;3(131):87–92. https://doiorg.publicaciones.saludcastillayleon.es/10.15574/SP.2023.131.87.

    Article  Google Scholar 

  23. Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in Penicillin-allergic patients: A literature review. J Emerg Med. 2012;42(5):612–20. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jemermed.2011.05.035.

    Article  PubMed  Google Scholar 

  24. Bogas G, Mayorga C, Martín-Serrano Á, Fernández-Santamaría R, Jiménez-Sánchez IM, Ariza A, et al. Penicillin and cephalosporin cross-reactivity: role of side chain and synthetic cefadroxil epitopes. Clin Translational Allergy. 2020;10(1):57. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13601-020-00368-1.

    Article  CAS  Google Scholar 

  25. Garcia-Nunez I, Algaba-Marmol M, Ignacio-Garcia J. Kounis syndrome after Lidocaine use. J Invest Allergy Clin Immunol. 2023;33(4):312–3. https://doiorg.publicaciones.saludcastillayleon.es/10.18176/jiaci.0876.

    Article  CAS  Google Scholar 

  26. Yilmaz E, Kaya Ç. Bupivacaine-Induced Kounis syndrome. Namık Kemal Tıp Dergisi. 2024;12(4):342–4. https://doiorg.publicaciones.saludcastillayleon.es/10.4274/nkmj.galenos.2024.70894.

    Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

No financial support or sponsorship.

Author information

Authors and Affiliations

Authors

Contributions

TB, OS - concept and study design, data interpretation, revision and supervising; NF, IP, LK, VB - acquisition and data analysis; TK - data interpretation, drafting and revision of manuscript. All the authors have read and approved the final version of the manuscript.

Corresponding author

Correspondence to Taras Kotyk.

Ethics declarations

Ethics approval and consent to participate

This case report was conducted in accordance with the principles outlined in the Declaration of Helsinki and adhered to ethical guidelines. Informed consent was obtained from the parents of the patient.

Consent for publication

Written informed consent was obtained from the parents of the patient for publication of this case report and accompanying images.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berezna, T., Synoverska, O., Fomenko, N. et al. Fatal pediatric case of Kounis syndrome and sepsis: a case report. Int J Emerg Med 18, 88 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12245-025-00886-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12245-025-00886-4

Keywords